Streaming Giants Intensify Content Race With Weekend Premieres Across Netflix Hulu Prime Video and Apple TV Treasury Rejects Proposal to Slash VAT on Public EV Charging Sources Say TIC Solutions Price Target Raised Following Mixed FirstQuarter Performance SpaceX Scrubs Starship Test Flight Reschedules for Friday as V3 Debut Approaches HighFlying Stocks Resist Splits Which May Be Next to Crack Intuit Inc Expands Enterprise Suite to Target MidMarket Business Growth LUNR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent SBFM Q1 2026 Earnings PreRevenue Biotech Reports Net Loss of 025 Per Share Stock Falls 25 BOBS Q1 2026 Earnings EPS Beats Estimates by Nearly 40 Despite Stock Decline ALKT Q1 2026 Earnings EPS Miss Sends Stock Higher as Investors Look to Profitability Path CRBP Q1 2026 Earnings Narrower Loss Beats Estimates but No Revenue and Sharp Share Decline Raise Concerns CRMD Q1 2026 Earnings Profit Surge Driven by NonOperating Items Revenue Remains Absent Nuveen Core Equity Alpha Fund JCE Trades Flat Amid Tight Range PMTV Remains Unchanged at 2523 as Bond Markets Digest Mixed Signals Nuveen Real Asset Income and Growth Fund JRI Edges Lower as Support Level Comes into Focus FCPT Stock Slips 05 as Investors Gauge Real Estate Sector Stability IO Biotech IOBT Holds Steady at 005 as Key Support and Resistance Converge Vital Farms Q1 2026 Earnings EPS Misses Estimates as Stock Rises 676 DPRO Q1 2026 Earnings WiderthanExpected Loss No Revenue Reported Stock Gains 288 FIS Q1 2026 Earnings EPS Beat Cushions the Blow as Stock Slips Progyny Inc PGNY Q1 2026 Earnings EPS Misses Estimates as Fertility Benefits Utilization Pressures Margins LAC Q1 2026 Earnings SmallerThanExpected Loss Amid Development Progress Glaukos GKOS Q1 2026 Earnings SmallerThanExpected Loss Fails to Lift Shares SEC Delays Regulatory Exemptions for Tokenized Stock Trading by Crypto Firms Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development Structure Therapeutics GPCR Shows Modest Gains as Biotech Sentiment Improves